Form 8-K - Current report:
SEC Accession No. 0001144204-17-043700
Filing Date
2017-08-16
Accepted
2017-08-16 16:22:45
Documents
9
Period of Report
2017-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v473390_8k.htm 8-K 34785
2 EXHIBIT 3.1 v473390_ex3-1.htm EX-3.1 94552
3 EXHIBIT 4.1 v473390_ex4-1.htm EX-4.1 113785
4 EXHIBIT 10.1 v473390_ex10-1.htm EX-10.1 249433
5 EXHIBIT 10.2 v473390_ex10-2.htm EX-10.2 140711
6 EXHIBIT 99.1 v473390_ex99-1.htm EX-99.1 10850
7 EXHIBIT 99.2 v473390_ex99-2.htm EX-99.2 10552
8 GRAPHIC image_001.jpg GRAPHIC 4078
9 GRAPHIC image_002.jpg GRAPHIC 4078
  Complete submission text file 0001144204-17-043700.txt   667726
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-53121 | Film No.: 171036571
SIC: 2834 Pharmaceutical Preparations